A lack of a proper pharmaceutical presentation of vecuronium used in paediatric anaesthesia may affect drug utilization and costs [5]

Paediatric Anaesthesia

Volumn 13, Issue 8, 2003, Pages 743-744

  Nava Ocampo, Alejandro A ^a,b   Salmerón, Jorge ^c   Garduño Espinosa, Juan ^c   Antonio Ocampo, Abdiel ^d  

^a HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^d HOSPITAL DE ESPECIALIDADES   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROMUSCULAR BLOCKING AGENT; VECURONIUM;

COST BENEFIT ANALYSIS; DOSE CALCULATION; DRUG COST; DRUG PACKAGING; DRUG USE; HUMAN; LETTER; PEDIATRIC ANESTHESIA; PHARMACEUTICS; PRIORITY JOURNAL;

AGE FACTORS; ANESTHESIA; CHILD; CHILD, PRESCHOOL; DOSAGE FORMS; DRUG UTILIZATION; HUMANS; INFANT, NEWBORN; MEXICO; NEUROMUSCULAR NONDEPOLARIZING AGENTS; PHARMACEUTICAL PREPARATIONS; VECURONIUM BROMIDE;

EID: 0142216152     PISSN: 11555645     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2003.01144.x     Document Type: Letter

References (5)

1. Fox-Quesada V. Primer informe de gobierno: Desarrollo social y humano-salud (equidad). Presidencia de la República, México, 2001 (URL: http://informe.presidencia.gob.mx/informes/ 2001Fox1).
2. Nava-Ocampo AA, Ramirez-Mora JC, Moyao-Garcia D, et al. Preferences of Mexican anesthesiologists for vecuronium, rocuronium, or other neuromuscular blocking agents: a survey. BMC Anesthesiol 2002; 2: 2 (URL: http://www. biomedcentral. com/1471-2253/2/2).
3. Canadian Pharmacists Association. Compendium of Pharmaceuticals and Specialties. Ottawa, ON, Canada: Canadian Pharmacists Association, 2002.
4. Association of the British Pharmaceutical Industry. Electronic Medicines Compendium (1999-2000). Datapharm Communications, Ltd, UK, 2002 (URL: http://emc.vhn.net/professional).
5. Center for Drug Evaluation and Research. The Electronic Orange Book, Food and Drug Administration, 2002 (URL: http:// www.fda.gov/cder).